Clay Siegall, Morphimmune CEO
Updated: Ex-Seagen chief Clay Siegall emerges as CEO of private biotech
Clay Siegall will be back in the CEO seat, taking the helm of a private startup working on targeted cancer therapies.
It’s been almost a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.